Skip to main content
. 2024 Aug 6;2024(8):CD014923. doi: 10.1002/14651858.CD014923.pub2

2. Summary of key characteristics of iNPH randomised controlled trials.

Study Study design Location Blinding Participants CSF testing entry criteria Radiological criteria Number randomised/shunted Intervention Published in medical literature
Tisell 2011 1‐arm, cross‐over RCT Single centre, Sweden Double (participant & assessor) Symptomatic iNPH > 60 years with Binswanger's Negative CSFTT and LIS Evans index > 0.3, Binswanger's disease* 14/14 VP shunt Full
Toma 2016 1‐arm, cross‐over RCT Single centre, UK Double (participant & assessor) Symptomatic iNPH > 60 years Positive ELD Evans index > 0.3 15/15 VP shunt Partial
Kazui 2015 1‐arm, cross‐over RCT Multicentre, Japan Not blinded Symptomatic iNPH > 60 years Normal CSF opening pressure Evans index > 0.3 and high‐convexity and medial subarachnoid space tightness 93/88 LP shunt Full
Luciano 2023 1‐arm, cross‐over RCT Multicentre: USA, Canada, Sweden Double (participant & assessor) Symptomatic iNPH > 60 years Positive CSFTT or ELD Evans index > 0.3 18/18 VP shunt Full

Abbreviations: CSF: cerebrospinal fluid; CSFTT: CSF tap‐test; ELD: external lumbar drain; iNPH: idiopathic normal pressure hydrocephalus; LIS: lumbar infusion study; LP: lumboperitoneal; RCT: randomised controlled trial; VP: ventriculoperitoneal

*Binswanger's disease defined by a score of 2 to 3 on Wahlund scale.